These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32493784)

  • 1. Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays.
    Heeringa M; Leav B; Smolenov I; Palladino G; Isakov L; Matassa V
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32493784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children.
    Moehling KK; Zimmerman RK; Nowalk MP; Jeng Lin C; Martin JM; Alcorn JF; Susick M; Burroughs A; Holiday C; Flannery B; Levine MZ
    Vaccine; 2020 Jul; 38(33):5171-5177. PubMed ID: 32580919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
    Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
    J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Dawood FS; Naleway AL; Flannery B; Levine MZ; Murthy K; Sambhara S; Gangappa S; Edwards L; Ball S; Grant L; Belongia E; Bounds K; Cao W; Gross FL; Groom H; Fry AM; Rentz Hunt D; Jeddy Z; Mishina M; Kim SS; Wesley MG; Spencer S; Thompson MG; Gaglani M
    Clin Infect Dis; 2021 Dec; 73(11):1973-1981. PubMed ID: 34245243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.
    Cowling BJ; Perera RAPM; Valkenburg SA; Leung NHL; Iuliano AD; Tam YH; Wong JHF; Fang VJ; Li APY; So HC; Ip DKM; Azziz-Baumgartner E; Fry AM; Levine MZ; Gangappa S; Sambhara S; Barr IG; Skowronski DM; Peiris JSM; Thompson MG
    Clin Infect Dis; 2020 Oct; 71(7):1704-1714. PubMed ID: 31828291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
    Williams KV; Zhai B; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Moehling Geffel K; Jaber Merranko A; Nagg JP; Collins M; Susick M; Clarke KS; Zimmerman RK; Martin JM
    Vaccine; 2022 Jan; 40(5):780-788. PubMed ID: 34952751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
    Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays.
    Morrison BJ; Martin NJ; Rehman T; Ewing D; Dewar RL; Metcalf J; Sun P; Beigel J; Luke TC; Raviprakash K
    BMC Health Serv Res; 2018 Aug; 18(1):651. PubMed ID: 30134892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement.
    Sicca F; Martinuzzi D; Montomoli E; Huckriede A
    Vaccine; 2020 Mar; 38(11):2527-2541. PubMed ID: 32044163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples.
    Otani N; Nakajima K; Ishikawa K; Ichiki K; Yoda Y; Ueda T; Takesue Y; Yamamoto T; Tanimura S; Shima M; Okuno T
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza A.
    Truelove S; Zhu H; Lessler J; Riley S; Read JM; Wang S; Kwok KO; Guan Y; Jiang CQ; Cummings DA
    Influenza Other Respir Viruses; 2016 Nov; 10(6):518-524. PubMed ID: 27406695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 Season.
    Gouma S; Zost SJ; Parkhouse K; Branche A; Topham DJ; Cobey S; Hensley SE
    Clin Infect Dis; 2020 Sep; 71(6):1447-1453. PubMed ID: 31598646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.
    Van Epps P; Tumpey T; Pearce MB; Golding H; Higgins P; Hornick T; Burant C; Wilson BM; Banks R; Gravenstein S; Canaday DH
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28100496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children.
    Verschoor CP; Singh P; Russell ML; Bowdish DM; Brewer A; Cyr L; Ward BJ; Loeb M
    PLoS One; 2015; 10(6):e0131531. PubMed ID: 26107625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.
    Hsu JP; Zhao X; Chen MI; Cook AR; Lee V; Lim WY; Tan L; Barr IG; Jiang L; Tan CL; Phoon MC; Cui L; Lin R; Leo YS; Chow VT
    BMC Infect Dis; 2014 Jul; 14():414. PubMed ID: 25066592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.
    Essink B; Fierro C; Rosen J; Figueroa AL; Zhang B; Verhoeven C; Edelman J; Smolenov I
    Vaccine; 2020 Jan; 38(2):242-250. PubMed ID: 31635976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.